Research team develops novel nanobody targeting tumor-fueling fluid to treat late-stage cancer of abdominal lining
Peritoneal metastases, a form of late-stage cancer that has spread to the lining of the abdominal cavity, carry a median survival of under nine months and currently have few effective treatments. A buildup of fluid in the abdomen known as ascites is known to actively fuel tumor growth, but the molec
<p>Peritoneal metastases, a form of late-stage cancer that has spread to the lining of the abdominal cavity, carry a median survival of under nine months and currently have few effective treatments. A buildup of fluid in the abdomen known as ascites is known to actively fuel tumor growth, but the molec</p>